Sensitivity and Specificity of Reiter Protein Complement-Fixation (RPCF) Test for Syphilis1  by Rein, Charles R. et al.
SENSITIVITY AND SPECIFICITY OF REITER PROTEIN
COMPLEMENT-FIXATION (RPCF) TEST FOR
SYPHILIS *
CHARLES R. REIN, M.D., LOUISE C. KELCEC, MT., G. D'ALESSANDRO, M.D.
ANT) J. H. Da BRUIJN, M.D.
(D'Alessandro and his co-workers reported on the separation of four different
fractions from the Reiter strain of Treponema pallidum (1, 2, 3). This report deals
with the thermolabile soluble protein extract of the Reiter treponeme. The anti-
gen employed in this study was prepared by de Bruijn (4) using the technic
described by D'Alessandro. The antigen is prepared briefly as follows: The Reiter
treponemes are grown in a Brewer thioglycollate medium. After harvesting the
washing, the treponemes are subjected to cryolysis. The lysate is dialyzed
against increasing concentrations of ammonium sulfate. The precipitate thus
obtained is dissolved in a veronal-huffered saline. This solution is dialyzed
against veronal-buffered saline to remove all traces of ammonium sulfate. The
dialysate is centrifuged at high speed, the supernate is preserved with "Merthio-
late" in a final concentration of 1: 10,000 and then lyophilized in 2 ml. aliquots.
This antigen is reconstituted with distilled water and submitted to antigen
titration prior to use. The reconstituted antigen is stored at 40C. It has remained
stabile until the contents of the vial have been completely used, approximately
three months to date.
The protein extract Reiter antigen was adapted to the one-fifth Kolmer technic
as employed by Portnoy and Magnuson (5) and to the Kent complement-fixation
technic employing three 50 per cent units of complement (6). The antigen titra-
tions were 1:80 with the former and 1:250 with the latter. Comparative studies
with the one-fifth volume Kolmer and the Kent 50 per cent end point technics
on identical specimens indicated that the results obtained with the latter were
more reproducible, easier to read with elimination of many anticomplementary
and partial anticomplementary reactions. Furthermore, the level of sensitivity
was comparable with the results obtained with the one-fifth Kolmer technic.
A total of 1055 random specimens were subjected to examination with the
Treponema pallidum complement-fixation (TPCF) and the Reiter protein com-
plement-fixation (RPCF) tests.
The purpose of this report is to evaluate the sensitivity and specificity of the
Reiter protein extract antigen in a series of serums obtained from "nonspecific"
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TABLE I
Treated early syphilis (94 patients)
NR WR R Not Done
Nontreponemal
Mazzini
VDRL
Rein-Bossak
Cardio. CF
Treponemal
TPI
TPIA
TPCF
RPCF
65
51
58
62
32
20
28
24
9
21
14
8
5
23
22
13
20
22
22
23
18
45
43
48
1
6
1
3
33
6
6
NR—Nonreactive (negative); WR—Weakly reactive (weakly positive); R—Reactive
(positive).
TABLE II
Treated late and latent syphilis (112 patients)
NR WR R Not Done
Nontreponemal
Mazzini
VDRL
Rein-Bossak
Cardio. CF
Treponemal
TPI
TPIA
TPCF
RPCF
19
5
8
10
2
0
3
7
14
22
22
5
2
5
18
16
79
85
82
94
30
107
88
86
3
1
3
3
77
or biologic false positive (BFP) reactors and syphilitic patients. These serums
were subjected to a series of four non-treponemal procedures including the
Mazzini (7), VDRL (7), Rein-Bossak (7) and Kent cardiolipin complement-
fixation (6) tests and to two or more treponemal procedures including the Trepo-
nema pallidum Immobilization (8) (TPI)*, Treponema pallidum Immune Ad-
herence (9, 10) (TPIA) and Treponema pallidum Complement-Fixation (5)
(TPCF) tests.
RESULTS
Tables I and II record the serologic results obtained in a series of 205 patients
in whom a definite diagnosis of treated early and late syphilis (including 15
patients with congenital syphilis) had been established. It will be noted that the
* The TPI tests were performed by Mr. Ad Harris (United States Public Health Service,
Chamblee, Georgia), Dr. James N. Miller (University of California at Los Angeles Medical
School) and Dr. A. H. Wheeler (University of Michigan Medical School).
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TABLE III
BFP reactors excluding lupus erythernatosus (84 patients)
NR WE R Not Done
Nontreponemal
Mazzini
VDRL
Rein-Bossak
Cardio. CF
Treponemal
TPI
TPIA
TPCF
RPCF
9
8
7
20
46
84
84
84
20
8
14
12
55
68
63
51 1
4 34
TABLE IV
BFP reactors in lupus erythematosus (15 patients)
Nontreponemal
Mazzini
VDRL
Rein-Bossak
Cardio. CF
Treponemal
TPIA
TPCF
RPCF
NR
5
2
2 .
2
15
12
15
WR
3
3
5
4
R
7
10
8
7 2
3
Not Done
sensitivity of the RPCF test compares favorably with that obtained with the other
treponemal procedures.
Tables III and IV record the serologic results obtained in a series of 99 patients
who were diagnosed as "nonspecific" biologic false positive (BFP) reactors. These
include 15 patients with lupus erythematosus. It will be noted that the specificity
was comparable with the results obtained with the other treponemal tests. In
fact, in no instance was any reactivity obtained with the RPCF test in these
groups.
A series of 36 seronegative patients with lupus erythematosus was also sub-
jected to examination with the nontreponemal and treponemal tests. The RCPF
test was nonreactive in all instances, as were the TPCF and TPIA tests.
The results obtained in this study compare favorably with those reported by
de Bruijn (4) and Cannefax and Garson (11).
SUMMARY
1. A series of 1055 serum specimens have been subjected to examination with
complement-fixation tests employing pathogenic Treponema pallidum and non-
pathogenic Reiter treponeme protein extract antigens.
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2. The one-fifth volume Kolmer and the Kent 50 per cent end point comple-
ment-fixation technics were used in this study. The results obtained with the
latter were more reproducible, easier to read with elimination of many anticom-
plementary and partial anticomplementary reactions. Furthermore, the level of
sensitivity was comparable with the results obtained with the one-fifth volume
Kolmer technic.
3. Sensitivity was evaluated in 206 patients with treated early, late and latent
syphilis. The results showed a level of reactivity comparable with that obtained
with the TPI, TPIA and TPCF tests.
4. Specificity was evaluated in 99 nonsyphilitic seropositive patients. The
results showed a degree of specificity equal to that obtained with the TPI, TPIA
and TPCF tests.
5. This preliminary investigation indicates that the Reiter protein extract
antigen employed in this study has a sensitivity and specificity comparable with
the TPI, TPIA and TPCF antigens.
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